arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

InspireMD, Inc.

NSPR
$0.72 0.00 (0.00%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
59 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
13
Health
Poor
Bearish
auto_awesome

Analytical Summary

InspireMD, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $60.3M
Dividend Yield
Revenue Growth 122.2%
Op. Margin -411.4%
ROIC -25.3%
FCF / Share $-0.15
Trailing P/E
Price / Book 0.8x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 6, 2026.

59-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$3.40M
↑ +122.2%
Net Income Profit after all expenses
$-13.69M
↓ -22.6%
Operating Margin Operating profit as % of sales
-411.4%
↓ -7.2%
FCF / Share Free cash flow per share
$-0.15
↑ +18.3%
Long-Term Debt Long-term obligations
$1.10M
↓ -48.8%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
0
Returns
10
Cash Quality
51

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 59 quarters